160 related articles for article (PubMed ID: 29268400)
21. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
[TBL] [Abstract][Full Text] [Related]
22. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
[TBL] [Abstract][Full Text] [Related]
23. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
24. Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
Liu W; Zhang Q; Zhang T; Li L; Xu C
Front Oncol; 2022; 12():1090544. PubMed ID: 36620572
[TBL] [Abstract][Full Text] [Related]
25. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
[TBL] [Abstract][Full Text] [Related]
26. The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm.
Xu L; Zhou H; Wang G; Huang Z; Xiong R; Sun X; Wu M; Li T; Xie M
Front Oncol; 2022; 12():954317. PubMed ID: 36033545
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study.
Sun S; Li S; Li J; Li X; Ding Y; Liu X; Wang K; Shi Y; Sun D
J Thorac Dis; 2022 Dec; 14(12):4846-4864. PubMed ID: 36647489
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
[TBL] [Abstract][Full Text] [Related]
29. Comparison of small biopsy and cytology specimens: Subtyping of pulmonary adenocarcinoma.
Ma C; Zhang L
Cytojournal; 2023; 20():5. PubMed ID: 36895259
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
[TBL] [Abstract][Full Text] [Related]
31. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
32. The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma.
Clay TD; Do H; Sundararajan V; Moore MM; Conron M; Wright GM; McLachlan SA; Dobrovic A; Russell PA
J Thorac Oncol; 2014 May; 9(5):654-63. PubMed ID: 24722155
[TBL] [Abstract][Full Text] [Related]
33. Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma.
Shigenobu T; Takahashi Y; Masugi Y; Hanawa R; Matsushita H; Tajima A; Kuroda H
Clin Lung Cancer; 2021 Nov; 22(6):e820-e828. PubMed ID: 33992533
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study.
Wu JJ; Wu CY; Wu CY; Wang CL; Yang TY; Tseng JS; Hsu KH; Huang YH; Hsu CP; Chuang CY; Lin CH; Tseng CH; Chen KC; Chang GC
J Formos Med Assoc; 2021 Feb; 120(2):874-882. PubMed ID: 32891489
[TBL] [Abstract][Full Text] [Related]
35. Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients.
Lu F; Li S; Dong B; Zhang S; Lv C; Yang Y
Thorac Cancer; 2016 Jan; 7(1):17-23. PubMed ID: 26816535
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
[TBL] [Abstract][Full Text] [Related]
37. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
Motoi N; Szoke J; Riely GJ; Seshan VE; Kris MG; Rusch VW; Gerald WL; Travis WD
Am J Surg Pathol; 2008 Jun; 32(6):810-27. PubMed ID: 18391747
[TBL] [Abstract][Full Text] [Related]
38. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]